Search results
Order by most recent / most popular / relevance
Results: 1-10 of 122
Pfizer v. Apotex, PMNOC Regulations decision
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- May 21 2010
Apotex alleged in its NOA that Pfizer's patent was invalid for double patenting, anticipation, obviousness, lack of utility and over-breadth
AstraZeneca v. Apotex; interlocutory motion for reply evidence; esomeprazole
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- February 12 2010
The Court dismissed AstraZeneca's appeal from the order of a prothonotary refusing to strike parts of Apotex' evidence and refusing to permit the applicants to file reply
Sanofi-Aventis v Pharmascience; 55.2 proceeding; motion to limit NOA based on issue estoppel; October 17, 2007 - ramipril
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- October 25 2007
The innovator brought a motion seeking a determination that the generic was precluded from making further allegations of invalidity by the doctrines of abuse of process, res judicata andor issue estoppel, on the basis that the same generic company had made a previous allegation of invalidity that had been found to have no merit
Pfizer v. Pharmascience, merits of NOC proceeding
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- January 20 2010
The Court granted prohibition to Pfizer and found that Pharmascience’s allegations of invalidity were not justified
Sanofi v. ApotexNovopharm
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- July 27 2009
The Court found the patent infringed, but invalid and thus dismissed two actions for infringement
Eli Lilly v. Apotex
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- May 4 2009
In the underlying decision on the merits, the Federal Court dismissed the application on the basis that the allegation as to a lack of sound prediction because the patent lacks adequate disclosure was justified
AstraZeneca v Novopharm, motion to adduce video-recordings of cross-examinations of expert witnesses in a PMNOC Regulations case
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- May 21 2010
AstraZeneca brought a motion seeking an order that video-recordings of cross-examinations of expert witnesses in the proceedings be filed as part of the Application Record and available at the hearing
Court overturns PMPRB's decisions in respect of the medicine copaxone
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- November 18 2009
On November 12, 2009, Justice Hughes of the Federal Court allowed two judicial review applications of Teva Neuroscience G.P.-S.E.N.C. in respect of two decisions made by the Patented Medicine Prices Review Board
Pfizer v. Apotex
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- April 7 2009
The Court upheld the decision of the Prothonotary refusing further production of ANDS documents
Sanofi-Aventis v. Laboratoire Riva; interlocutory motion on 55.2 proceeding; December 14, 2007 - Ramipril
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- January 17 2008
After cross-examinations had taken place, and approximately one week before the application record of Sanofi-Aventis was due, Riva brought a motion for leave to file further evidence
Current Search
- Workarea - Healthcare
- Workarea - Intellectual Property
- Workarea - Litigation
- Firm Name - Gowling Lafleur Henderson LLP
Suggested Facets
Author
- Adrienne Blanchard (1)
- Beverley Moore (49)
- Graham Ragan (1)
- Jane E. Clark (1)
- Jennifer Wilkie (1)
- Natalie de Paulsen (1)
- Patrick Stewart Smith (1)
- Scott Foster (9)